Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Oct 30;10(10):CD009622.
doi: 10.1002/14651858.CD009622.pub5.

Gamma aminobutyric acid (GABA) receptor agonists for acute stroke

Jia Liu  1 , Jing Zhang, Lu-Ning Wang
Affiliations
Meta-Analysis

Gamma aminobutyric acid (GABA) receptor agonists for acute stroke

Jia Liu et al. Cochrane Database Syst Rev. .

Abstract

Background: Gamma aminobutyric acid (GABA) receptor agonists have been shown to have a neuroprotectant effect in reducing infarct size and improving functional outcome in animal models of cerebrovascular disease. However, the sedative effects of GABA receptor agonists have limited their wider application in people with acute stroke, due to the potential risk of stupor. This is an update of a Cochrane Review first published in 2013, and previously updated in 2014 and 2016.

Objectives: To determine the efficacy and safety of GABA receptor agonists in the treatment of acute stroke.

Search methods: We searched the Cochrane Stroke Group Trials Register (accessed May 2018), the Cochrane Central Register of Controlled Trials (CENTRAL) 2018, Issue 4 (accessed May 2018), MEDLINE (from 1949 to May 2018), Embase (from 1980 to May 2018), CINAHL (from 1982 to May 2018), AMED (from 1985 to May 2018), and 11 Chinese databases (accessed May 2018). In an effort to identify further published, unpublished, and ongoing trials we searched ongoing trial registers, reference lists, and relevant conference proceedings, and contacted authors and pharmaceutical companies.

Selection criteria: We included randomized controlled trials (RCTs) investigating GABA receptor agonists versus placebo for people with acute stroke (within 12 hours after stroke onset), with the primary outcomes of efficacy and safety.

Data collection and analysis: Two review authors independently screened the titles and abstracts of identified records, selected studies for inclusion, extracted eligible data, cross-checked the data for accuracy, and assessed the risk of bias. We used the GRADE approach to assess the quality of the evidence.

Main results: We included five trials with 3838 participants (acute ischemic or hemorrhagic stroke patients, 3758 analyzed). Most of the participants recruited had acute ischaemic stroke, with limited data available from participants with other stroke subtypes, including total anterior circulation syndrome (TACS). The methodological quality of the included trials was generally good, with an unclear risk for selection bias only. For death and dependency at three months, pooled results did not find a significant difference for chlormethiazole versus placebo (risk ratio (RR) 1.03, 95% confidence interval (CI) 0.96 to 1.11; four trials; 2909 participants; moderate-quality evidence) and for diazepam versus placebo (RR 0.94, 95% CI 0.82 to 1.07; one trial; 849 participants; moderate-quality evidence). The most frequent adverse events related to chlormethiazole were somnolence (RR 4.56, 95% CI 3.50 to 5.95; two trials; 2527 participants; moderate-quality evidence) and rhinitis (RR 4.75, 95% CI 2.67 to 8.46; two trials; 2527 participants; moderate-quality evidence).

Authors' conclusions: This review provides moderate-quality evidence that fails to support the use of GABA receptor agonists (chlormethiazole or diazepam) for the treatment of people with acute stroke. More well-designed RCTs with large samples of participants with total anterior circulation syndrome are required to determine if there are benefits for this subgroup. Somnolence and rhinitis are frequent adverse events related to chlormethiazole.

PubMed Disclaimer

Conflict of interest statement

Jia Liu: none known. Jing Zhang: none known. Lu‐Ning Wang: none known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Efficacy and safety for acute stroke, Outcome 1 Death or dependency.
1.2
1.2. Analysis
Comparison 1 Efficacy and safety for acute stroke, Outcome 2 Somnolence.
1.3
1.3. Analysis
Comparison 1 Efficacy and safety for acute stroke, Outcome 3 Rhinitis.
1.4
1.4. Analysis
Comparison 1 Efficacy and safety for acute stroke, Outcome 4 Functional independence.
2.1
2.1. Analysis
Comparison 2 Efficacy for acute ischemic stroke, Outcome 1 Death or dependency.
2.2
2.2. Analysis
Comparison 2 Efficacy for acute ischemic stroke, Outcome 2 Functional independence.
3.1
3.1. Analysis
Comparison 3 Efficacy for acute hemorrhagic stroke, Outcome 1 Death or dependency.
3.2
3.2. Analysis
Comparison 3 Efficacy for acute hemorrhagic stroke, Outcome 2 Functional independence.
4.1
4.1. Analysis
Comparison 4 Efficacy for TACS, Outcome 1 Functional independence.
5.1
5.1. Analysis
Comparison 5 Efficacy for early‐treated acute stroke, Outcome 1 Functional independence.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Lodder 2006 {published data only}
    1. Lodder J, Raak L, Hilton A, Hardy E, Kessels A. Diazepam to improve acute stroke outcome: results of the early GABA‐ergic activation study in stroke trial. A randomized double‐blind placebo controlled trial. Cerebrovascular Diseases (Basel, Switzerland) 2006;21(1‐2):120‐7. - PubMed
    1. Raak L, Hilton A, Kessels F, Lodder J. Implementing the EGASIS trial, an international multicenter acute intervention trial in stroke. Controlled Clinical Trials 2002;23(1):74‐9. - PubMed
Lyden 2000 {published data only}
    1. Lyden PD, Shuaib A, Ng K, Atkinson R, Ashwood T, Nordlund A, et al. The Clomethiazole Acute Stroke Study in Hemorrhagic Stroke (CLASS‐H): final results. Journal of Stroke and Cerebrovascular Diseases 2000;9(6):268‐75.
Lyden 2001 {published data only}
    1. Lyden P, Jacoby M, Schim J, Albers G, Mazzeo P, Ashwood T, et al. The clomethiazole acute stroke study in tissue‐type plasminogen activator‐treated stroke (CLASS‐T). Neurology 2001;57(7):1199‐205. - PubMed
Lyden 2002 {published data only}
    1. Lyden P, Shuaib A, Levin K, Atkinson RP, Rajput A, Wechsler L, et al. Clomethiazole acute stroke study in ischemic stroke (CLASS‐I): final results. Stroke 2002;33(1):122‐8. - PubMed
    1. Millis SR, Straube D, Iramaneerat C, Smith EV Jr, Lyden P. Measurement properties of the National Institutes of Health Stroke Scale for people with right‐ and left‐hemisphere lesions: further analysis of the clomethiazole for Acute Stroke Study‒Ischemic (CLASS‐I) trial. Archives of Physical Medicine and Rehabilitation 2007;88(3):302‐8. - PubMed
Wahlgren 1999 {published data only}
    1. Wahlgren NG, Bornhov S, Sharma A, Cederin B, Rosolacci T, Ashwood T, et al. The Clomethiazole Acute Stroke Study (CLASS): Efficacy results in 545 patients classified as Total Anterior Circulation Syndrome (TACS). Journal of Stroke and Cerebrovascular Diseases 1999;8(4):231‐9. - PubMed
    1. Wahlgren NG, Diez‐Tejador E, Teitelbaum J, Arboix A, Leys D, Ashwood T, et al. Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients. Stroke 2000;31(1):82‐5. - PubMed
    1. Wahlgren NG, Matias Guiu J, Lainez JM, Veloso F, Ranasinha K, Grossman E, et al. The Clomethiazole Acute Stroke Study (CLASS): safety results in 1,356 patients with acute hemispheric stroke. Journal of Stroke and Cerebrovascular Diseases 2000;9(4):158‐65. - PubMed
    1. Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, Erven PM, Ashwood T, et al. Clomethiazole acute stroke study (CLASS). Results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke 1999;30(1):21‐8. - PubMed

References to studies excluded from this review

Agarwal 2017 {published data only}
    1. Agarwal S, Patel T, Shah N, Patel BM. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity. Biomedicine & Pharmacotherapy 2017;87:628‐35. - PubMed
Chow 2017 {published data only}
    1. Chow JW, Yablon SA, Stokic DS. Intrathecal baclofen bolus reduces exaggerated extensor coactivation during pre‐swing and early‐swing of gait after acquired brain injury. Clinical Neurophysiology 2017;128(5):725‐33. - PubMed
Darmani 2016 {published data only}
    1. Darmani G, Zipser CM, Böhmer GM, Deschet K, Müller‐Dahlhaus F, Belardinelli P, et al. Effects of the selective α5‐GABAAR antagonist S44819 on excitability in the human brain: a TMS‐EMG and TMS‐EEG phase I study. Journal of Neuroscience 2016;36(49):12312‐20. - PMC - PubMed
Lyden 1998 {published data only}
    1. Lyden PD, Ashwood T, Claesson L, Odergren T, Friday GH, Martin‐Munley S. The clomethiazole acute stroke study in ischemic, hemorrhagic, and t‐PA treated stroke: design of a phase III trial in the United States and Canada. Journal of Stroke and Cerebrovascular Diseases 1998;7(6):435‐41. - PubMed
Nepveu 2017 {published data only}
    1. Nepveu JF, Thiel A, Tang A, Fung J, Lundbye‐Jensen J, Boyd LA, et al. A single bout of high‐intensity interval training improves motor skill retention in individuals with stroke. Neurorehabilitation and Neural Repair 2017;31(8):726‐35. - PubMed
Zhang 2014 {published data only}
    1. Zhang C, Zhang R, Zhang S, Xu M, Zhang S. Baclofen for stroke patients with persistent hiccups: a randomized, double‐blind, placebo‐controlled trial. Trials 2014;15:295. - PMC - PubMed

Additional references

AHA 2002
    1. American Heart Association. 2002 Heart and Stroke Facts Statistical Update. Dallas: American Heart Association, 2002.
Alicke 1995
    1. Alicke B, Schwartz‐Bloom RD. Rapid down‐regulation of GABAA receptors in the gerbil hippocampus following transient cerebral ischemia. Journal of Neurochemistry 1995;65(6):2808‐11. - PubMed
Bath 2001
    1. Bath PM, Iddenden R, Bath FJ, Orgogozo JM, Tirilazad International Steering Committee. Tirilazad for acute ischemic stroke. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD002087] - DOI - PubMed
Bath 2004
    1. Bath PMW, Bath‐Hextall FJ. Pentoxifylline, propentofylline and pentifylline for acute ischemic stroke. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD000162.pub2] - DOI - PubMed
Candelise 2001
    1. Candelise L, Ciccone A. Gangliosides for acute ischemic stroke. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000094] - DOI - PubMed
Chi 2011
    1. Chi OZ, Hunter C, Liu X, Chi Y, Weiss HR. Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood‐brain barrier disruption in focal cerebral ischemia. Journal of Neurological Sciences 2011;301((1‐2)):66‐70. - PubMed
Cruz‐Flores 2011
    1. Cruz‐Flores S. Ischemic stroke in emergency medicine. emedicine.medscape.com/article/1916852‐overview (accessed 9 June 2011).
Egger 1997
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple graphical test. BMJ 1997;315(7109):629‐34. - PMC - PubMed
Gandolfo 2002
    1. Gandolfo C, Sandercock P, Conti M. Lubeluzole for acute ischemic stroke. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD001924] - DOI - PubMed
Gasior 2004
    1. Gasior M, Witkin JM, Goldberg SR, Munzar P. Chlormethiazole potentiates the discriminative stimulus effects of methamphetamine in rats. European Journal of Pharmacology 2004;494(2‐3):183‐9. - PubMed
Hanna 1996
    1. Hanna JP, Frank JI, Furlan AJ, Sila SA, Secic S. Prediction of worsening consciousness from edema after hemispheric infarction. Journal of Stroke and Cerebrovascular Diseases 1996;6(1):25‐9. - PubMed
Higgins 2011
    1. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Horn 2000
    1. Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD001928] - DOI - PubMed
Klassman 2011
    1. Klassman L. Therapeutic hypothermia in acute stroke. Journal of Neuroscience Nursing 2011;43(2):94‐103. - PubMed
Marshall 2003
    1. Marshall JW, Green AR, Ridley RM. Comparison of the neuroprotective effect of clomethiazole, AR‐R15896AR and NXY‐059 in a primate model of stroke using histological and behavioural measures. Brain Research 2003;972(1‐2):119‐26. - PubMed
Muir 2003
    1. Muir KW, Lees KR. Excitatory amino acid antagonists for acute stroke. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD001244] - DOI - PMC - PubMed
Nelson 2000
    1. Nelson RM, Green AR, Lambert DG, Hainsworth AH. On the regulation of ischemia‐induced glutamate efflux from rat cortex by GABA: in vitro studies with GABA, clomethiazole and pentobarbitone. British Journal of Pharmacology 2000;130(5):1124‐30. - PMC - PubMed
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Saka 2009
    1. Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age and Ageing 2009;38(1):27‐32. - PubMed
Simon 2009
    1. Simon RP, Greenberg DA, Aminoff MJ. Stroke. Clinical Neurology. 7th Edition. New York: McGraw‐Hill, 2009:292‐327.
Sulter 1999
    1. Sulter G, Steen C, Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30(8):1538‐41. - PubMed
Sydserff 2002
    1. Sydserff SG, Borelli AR, Green AR, Cross AJ. Effect of NXY‐059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat: studies on dose, plasma concentration and therapeutic time window. British Journal of Pharmacology 2002;135(1):103‐12. - PMC - PubMed
Tuttolomondo 2009
    1. Tuttolomondo A, Sciacca R, Raimondo D, Arnao V, Renda C, Pinto A, et al. Neuron protection as a therapeutic target in acute ischemic stroke. Current Topics in Medicinal Chemistry 2009;9(14):1317‐34. - PubMed
Vaishnav 2002
    1. Vaishnav A, Lutsep HL. GABA agonist: clomethiazole. Current Medical Research and Opinion 2002;18(Suppl 2):S5‐8. - PubMed
Visser 2005
    1. Visser SA, Pozarek S, Martinsson S, Forsberg T, Ross SB, Gabrielsson J. Rapid and long‐lasting tolerance to clomethiazole‐induced hypothermia in the rat. European Journal of Pharmacology 2005;512(2‐3):139‐51. - PubMed
Warlow 2001
    1. Warlow CP, Dennis MS, Gijn J, Hankey GJ, Sandercock PAG, Bamford JM, et al. What caused this transient or persistent ischemic event?. Stroke: A Practical Guide to Management. 2nd Edition. Oxford: Wiley‐Blackwell, 2001.
WHO 2011
    1. World Health Organization. The atlas of heart disease and stroke. who.int/cardiovascular_diseases/resources/atlas/en (accessed 9 June 2011).
Wilby 2004
    1. Wilby MJ, Hutchinson PJ. The pharmacology of chlormethiazole: a potential neuroprotective agent?. CNS Drug Reviews 2004;10(4):281‐94. - PMC - PubMed
Zingmark 2003
    1. Zingmark PH, Ekblom M, Odergren T, Ashwood T, Lyden P, Karlsson MO, et al. Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. British Journal of Clinical Pharmacology 2003;56(2):173‐83. - PMC - PubMed
Zubcevic 2010
    1. Zubcevic J, Potts JT. Role of GABAergic neurons in the nucleus tractus solitarii in modulation of cardiovascular activity. Experimental Physiology 2010;95(9):909‐18. - PubMed

References to other published versions of this review

Liu 2013
    1. Liu J, Wang LN. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD009622.pub2] - DOI - PubMed
Liu 2014
    1. Liu J, Wang LN. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD009622.pub3] - DOI - PubMed
Liu 2016
    1. Liu J, Wang LN. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database of Systematic Reviews 2016, Issue 10. [DOI: 10.1002/14651858.CD009622.pub4] - DOI - PMC - PubMed

MeSH terms